NASDAQ Biotechnology NBI Index
4308.87 USD
{{ price }}
0.781592%
{{change_pct}}%
Land
Vereinigte Staaten
Börse
Nasdaq GIDS
Tief - Hoch[24 Std]
4267.79
-
4314.65 USD
Anzahl der Komponenten
389
NASDAQ Biotechnology Kurs Chart
Top 5 Gewinner der letzten 24 Stunden
| CVAC | CureVac | +37.11% | |
|---|---|---|---|
| EGRX | Eagle Pharmaceuticals | +15% | |
| PHAT | Phathom Pharmaceuticals | +10.12% | |
| NXTC | NextCure | +7.85% | |
| EDIT | Editas Medicine | +6.39% |
Top 5 Verlierer der letzten 24 Stunden
| RUBY | Rubius Therapeutics | —% | |
|---|---|---|---|
| ONCR | Oncorus | —% | |
| SYRS | Syros Pharmaceuticals | -18.97% | |
| TNXP | Tonix Pharmaceuticals Holding | -12.06% | |
| HBIO | Harvard Bioscience | -8.31% |
NASDAQ Biotechnology NBI FINANZEN UND HANDELSÜBERSICHT
| NASDAQ Biotechnology Index Kurs | 4308.87 USD |
| Kurs Vortag | 4145.3 USD |
| Öffnen | 4144.01 USD |
| Gebot | 0 USD x 0 |
| Briefkurs | 0 USD x 0 |
| Tagesspanne | 4120.59 - 4212.44 USD |
| 52-Wochen-Spanne | 3568.35 - 4954.81 USD |
| Volumen | 0 USD |
| Durchschn. Volumen | 0 USD |
Handelsinformationen
NASDAQ Biotechnology Index Kursverlauf
| 52-Wochen-Hoch | 4954.81 USD |
| 52-Wochen-Tief | 3568.35 USD |
| Gleitender Durchschnitt 50 Tage | 4100.46 USD |
| Gleitender Durchschnitt 200 Tage | 4481.1 USD |
Indexstatistiken für NBI
| Durchschn. Vol. (3 M.) | 0 USD |
| Durchschn. Vol. (10 Tage) | 0 USD |
Q&A für NASDAQ Biotechnology Index
Was ist der aktuelle NBI Index Kurs?
NASDAQ Biotechnology NBI Index Kurs beträgt heute 4308.87 USD.
Wie kann ich den NASDAQ Biotechnology Index kaufen?
Sie können den NBI Index an der Börse Nasdaq GIDS kaufen. Kontaktieren Sie Ihren Finanzberater, um einen Broker auszuwählen.
Was ist das Tickersymbol für NASDAQ Biotechnology?
Das Tickersymbol oder der Index für NASDAQ Biotechnology ist NBI.
Wie viele Komponenten enthält der NASDAQ Biotechnology Index?
NASDAQ Biotechnology Index enthält 389 Komponenten.
Welchem Land gehört der NASDAQ Biotechnology Index an?
NASDAQ Biotechnology Index gehört zu United States.
Zu welcher Börse gehört der NASDAQ Biotechnology Index?
NASDAQ Biotechnology Index gehört zur Börse Nasdaq GIDS.
NASDAQ Biotechnology KOMPONENTEN
| Name Name | Kurs Kurs |
24h% 7d chart 24h% & 7d |
Marktkap. Marktkap. | Vol. Volumen | 24Std Tief | 24Std Hoch | Marktkap. | KGV | EPS |
|---|
| Name Name | Kurs Kurs |
24h% 7d chart 24h% & 7d |
Marktkap. Marktkap. | Vol. Volumen | 24Std Tief | 24Std Hoch | Marktkap. | KGV | EPS |
|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
| AstraZeneca AZN | $74.72 — |
+1.33
|
$231.66B — | $599.28K — | $74.26 — | $74.85 — | $231.66B — | 30.00 | $2.49 — |
| Amgen AMGN | $295.68 — |
+1.32
|
$158.99B — | $381.14K — | $292.68 — | $296 — | $158.99B — | 26.95 | $10.97 — |
| Gilead Sciences GILD | $109.35 — |
+0.05
|
$136.02B — | $1.12M — | $108.9 — | $110.54 — | $136.02B — | 23.02 | $4.75 — |
| Sanofi SNY | $50.74 — |
+2.09
|
$124.41B — | $389.02K — | $50.04 — | $50.84 — | $124.41B — | 17.80 | $2.85 — |
| Vertex Pharmaceuticals Incorporated VRTX | $456.79 — |
+0.96
|
$117.3B — | $150.89K — | $451.94 — | $457.45 — | $117.3B — | 0 | -$3.8 — |
| Regeneron Pharmaceuticals REGN | $521.9 — |
+0.64
|
$56.35B — | $104.78K — | $512.97 — | $522.56 — | $56.35B — | 13.25 | $39.36 — |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — |
| Alnylam Pharmaceuticals ALNY | $305.85 — |
+2.43
|
$39.88B — | $135.4K — | $295.82 — | $307.24 — | $39.88B — | 0 | -$2.09 — |
| argenx SE ARGX | $578.15 — |
+0.55
|
$35.64B — | $29.63K — | $576.22 — | $580.67 — | $35.64B — | 35.27 | $16.39 — |
| BioNTech SE BNTX | $105.97 — |
+0.48
|
$25.47B — | $697.18K — | $104 — | $108 — | $25.47B — | 0 | -$3.65 — |
| BeiGene BGNE | $184.72 — |
0
|
$20.21B — | $0 — | $0 — | $0 — | $20.21B — | 0 | $0 — |
| Royalty Pharma RPRX | $34.92 — |
+2.56
|
$19.63B — | $1.89M — | $34.14 — | $34.93 — | $19.63B — | 14.25 | $2.45 — |
| Biogen BIIB | $133.07 — |
<0.01
|
$19.5B — | $47.67K — | $132.06 — | $133.08 — | $19.5B — | 13.13 | $10.13 — |
| Insmed Incorporated INSM | $97.91 — |
-0.07
|
$17.83B — | $2.34M — | $96.5 — | $100 — | $17.83B — | 0 | -$5.93 — |
| Summit Therapeutics SMMT | $19.77 — |
+0.94
|
$14.68B — | $1.07M — | $19.26 — | $19.93 — | $14.68B — | 0 | -$0.34 — |
| Genmab A/S GMAB | $23.02 — |
+1.72
|
$14.26B — | $314.61K — | $22.77 — | $23.06 — | $14.26B — | 13.54 | $1.7 — |
| Intra-Cellular Therapies ITCI | $131.87 — |
0
|
$14.05B — | $0 — | $0 — | $0 — | $14.05B — | 0 | $0 — |
| Illumina ILMN | $87.98 — |
+0.5
|
$13.93B — | $129.74K — | $87.09 — | $88.53 — | $13.93B — | 0 | -$6.08 — |
| Incyte INCY | $69.44 — |
+0.86
|
$13.44B — | $290.81K — | $68.1 — | $69.47 — | $13.44B — | 347.19 | $0.2 — |
| United Therapeutics UTHR | $280.6 — |
+1.49
|
$12.66B — | $120.95K — | $275.59 — | $282.39 — | $12.66B — | 11.17 | $25.1 — |
- {{ link.label }} {{link}}